Mechanism of action: molecular mimicry and lysis
The mode of action of these drugs is based on structural mimicry. The antibiotic molecule is a structural analog of the terminal part of the peptidoglycan peptide chain—the D-alanyl-D-alanine dipeptide (D-Ala-D-Ala).
The process of bacterial destruction takes place in two stages:
- Inhibition of synthesis (primary target). The drug covalently binds to the active center of the transpeptidase enzyme. This blocks the transpeptidation reaction, which is vital for cross-linking peptidoglycan chains. As a result, the bacterium cannot build a complete cell wall.
- Activation of lysis (secondary effect). In parallel, the antibiotic inhibits the endogenous autolysin inhibitor. This leads to a sharp increase in the activity of autolysins themselves—enzymes that normally neatly cleave peptidoglycan only for cell division.
The result of this double blow is the arrest of cell wall synthesis against the background of uncontrolled activity of destructive enzymes, which inevitably leads to autocytolysis (cell death). It is important to remember that these drugs only work against actively dividing (growing) bacteria, as intensive peptidoglycan synthesis occurs precisely in this phase.
Classification and structure
Beta-lactams belong to a large group of cell wall synthesis inhibitors. In addition to them, this category includes glycopeptides, cycloserine, bacitracin, and phosphonic acid derivatives.
Beta-lactam antibiotics themselves are divided into four main subgroups:
- Penicillins;
- Cephalosporins;
- Carbapenems;
- Monobactams.
All of them share a similar chemical structure that determines a uniform mechanism of action. The key element of the molecule is the β-lactam ring. There is a strict structure-function relationship: this ring is critical for antimicrobial activity. If it is cleaved, the drug completely loses its pharmacological effect. The main structural vulnerability is that the ring can be destroyed by specific bacterial enzymes—β-lactamases.
Barrier penetration and spectrum of activity
To reach its target (bacterial transpeptidases), the antibiotic needs to penetrate the periplasmic space, which is located between the cytoplasmic membrane and the cell wall.
To do this, the drug must overcome the cell wall itself, and in the case of Gram-negative bacteria, also an additional barrier in the form of the outer membrane.
The spectrum of activity of any β-lactam depends on two key parameters:
- The degree of penetration through the microorganism's protective membranes.
- The affinity of the molecule for transpeptidases of a specific bacterium.
Mechanisms of bacterial resistance
Bacteria actively develop resistance to β-lactams, which is of enormous clinical significance. For example, due to high gonococcal resistance, benzylpenicillin is no longer used for the empiric therapy of gonorrhea.
Genetically, resistance can be due to chromosomal (intrinsic) or acquired (extrinsic) genes. Taking Gram-positive bacteria as an example, the main biochemical defense mechanism is the alteration of the drug target (transpeptidase). This is achieved in two ways:
- Chromosomal pathway: a mutation of the transpeptidase gene occurs, leading to a decrease in the enzyme's affinity for the antibiotic.
- Acquired pathway: the bacterium acquires a new gene from the outside that encodes a transpeptidase with an initially low affinity for the drug.
Classic examples of such defense are the resistance of S. aureus to methicillin and acquired penicillin resistance in pneumococci.
Briefly: answers to topical questions
What are the side effects of penicillins?
When using penicillins, the main risk is allergic reactions, and organotoxicity is also possible.
- Allergic reactions—manifest as anaphylactic shock, urticaria, angioedema, and various rashes.
- Nephrotoxicity—acute interstitial nephritis may rarely develop.
- Neurotoxicity—seizures may develop when high doses of benzylpenicillin are used.
In general, drugs of this group are usually well tolerated by patients.
What are the generations of cephalosporins?
Cephalosporins are divided into 4 generations, within which drugs are distinguished into parenteral and oral.
| Generation | Parenteral drugs | Oral drugs |
|---|---|---|
| 1st generation | Cefazolin | Cephalexin, Cefadroxil |
| 2nd generation | Cefuroxime, Cefoxitin, Cefotetan, Cefamandole | Cefuroxime axetil, Cefaclor |
| 3rd generation | Cefotaxime, Ceftriaxone, Ceftazidime, Cefoperazone | Cefixime, Ceftibuten |
| 4th generation | Cefepime, Cefpirome | Absent |
Drugs of different generations differ in their spectrum of antibacterial activity and resistance to bacterial enzymes.
Which agents belong to the carbapenem group?
The carbapenem group includes antibiotics with a cell wall synthesis-inhibiting mechanism of action.
- Imipenem—is rapidly degraded in the renal tubules by dehydropeptidase I, and is therefore used exclusively in a fixed combination with an inhibitor of this enzyme (cilastatin).
- Meropenem—is used for late-onset neonatal sepsis and as an adjunctive drug in the treatment of tuberculosis.
These drugs are not absorbed in the gastrointestinal tract and are administered only parenterally.
Which beta-lactamase inhibitors are used in clinical practice?
Several $\beta$-lactamase inhibitors are used in clinical practice to protect antibiotics from destruction by bacterial enzymes.
- Clavulanic acid has weak intrinsic antibacterial activity and is used in combination with penicillins (amoxicillin, ticarcillin) and carbapenems.
- Sulbactam is used as part of combination drugs, for example, with ampicillin.
- Tazobactam contains a $\beta$-lactam ring and irreversibly inactivates bacterial enzymes.
- Avibactam is used as an additive to block $\beta$-lactamases.
These substances bind to enzymes and prevent the hydrolysis of the primary antibiotic.
To memorize the mechanism of action, imagine a Trojan horse: the antibiotic mimics a building block (D-Ala-D-Ala), binds to the building enzyme (transpeptidase), and blocks it. At the same time, the bacterium loses control over destructive enzymes (autolysins) and destroys itself.
Class and exam questions
Why don't beta-lactams affect "dormant" bacteria?
The drugs are effective only against actively growing microorganisms. It is precisely during the division phase that intensive synthesis of the cell wall peptidoglycan occurs, a process that antibiotics disrupt.
What happens if the beta-lactam ring is destroyed?
This ring is critically important for antimicrobial activity. Its cleavage (e.g., by bacterial β-lactamases) leads to a complete loss of pharmacological effect.
How does resistance to beta-lactams develop in gram-positive bacteria?
The main reason is target modification. The bacterium mutates or acquires a new gene, causing its transpeptidases to lose affinity for the antibiotic.
What else to study on this topic
- Structural features of the bacterial cell wall and outer membrane.
- The role of β-lactamases in the development of antibiotic resistance.
- Differences between penicillins, cephalosporins, carbapenems, and monobactams.
- Mechanisms of action of other cell wall synthesis inhibitors (glycopeptides, cycloserine, bacitracin).
Master the entire topic in the «Pharmacology» course
This is a summary. The course covers everything tested in classes and exams.
- Complete study guide on "Beta-lactam antibiotics" and 5,304 more pages of the subject
- Assignments and quizzes after every topic — just like in a colloquium
- AI tutor answers questions on the topic anytime
- 116 video lessons on the subject
Other topics in the section "Antibacterial Chemotherapeutic Agents"
Free video lessons: pharmacologyShort lessons with study notes — no registration required.
Prepared by WhiteCoat Pro faculty in accordance with the medical school curriculum. For educational purposes only.